Protein C, Total Antigen
Protein C is an anticoagulant and proenzyme produced in the liver and is found circulating in the plasma. Protein C is activated by thrombin to become activated Protein C (APC). Activated Protein C acts as an anticoagulant by inactivating the activated factors Va and VIIIa, which are coagulation factors needed for clot formation. Inactivating Va and VIIIa will stop further thrombin production and block the coagulation cycle. Another proenzyme, Protein S, when present, will enhance the effects of activated protein C.
Inherited heterozygous protein C deficiency is an autosomal dominant genetically acquired disorder that affects less than 0.5% of the population. Patients who are homozygous for protein C deficiency (rare) will suffer from massive venous thrombosis at birth (purpura fulminans). Acquired protein C deficiency can also occur as a consequence of liver disease, anticoagulation therapy, and vitamin K deficiency. Those with protein C deficiency will usually be in a hypercoagulable state (increased coagulation) with abnormal clotting such as pulmonary embolism or deep vein thrombosis (DVT). Protein C deficiency is either type I (quantitative) or type II (qualitative). In type I deficiency, protein C functions correctly, but is present in decreased amounts. In type II deficiency, an adequate amount of protein C is present but it does not function correctly. Therefore it is very important to test for both protein C activity and protein C antigen amount. Typically protein C activity is tested initially and if the activity is decreased, an antigenic test will be performed to determine the category of disease.
- Diagnosis of Protein C deficiency (type I or type II)
- As an aid in diagnosis of Protein C deficiency other than inherited (in liver disease, vitamin K deficiency, warfarin therapy)
- As an aid in evaluation of disseminated intravascular coagulation or DIC
- As an aid in evaluation of Deep Vein Thrombosis
- As an aid in evaluation hypercoagulable states
- Evaluation of family history of thrombotic events
Decreased in:
- Congenital (hereditary) deficiency
- Liver disease
- Cirrhosis
- Warfarin use
- Vitamin K deficiency
- Disseminated Intravascular Coagulation (DIC)
- Deep Vein Thrombosis (DVT)
- Other acute thrombotic event
- Acute illness
Interfering Factors: Falsely decreased functional protein C values may be seen in patients with abnormally elevated levels of factor VIII. Also, falsely increased levels of functional protein C values may be seen in patients on heparin therapy.
Birth: 15% – 50%
Six Months – 16 years: 50% of adult normal values
Adult: 70% -150%
Note: Results are reported as a percent of the amount expected in normal plasma.
Platelet-poor Plasma Citrate (Light Blue top).
Freeze immediately and maintain frozen until tested.
Stability
- Ambient: Unacceptable
- Refrigerated: Unacceptable
- Frozen: 14 days
Patients on Coumadin should have testing delayed until they have stopped the drug for 10 days as Coumadin decreased protein C levels.
- J Thromb Haemost. 2005;3:1428. [PMID: 15978099]
- J Thromb Haemost. 2005;3:459. [PMID: 15748234]
- Haematologica. 2006;91:695. [PMID: 16670075]
- Jacobs DS and DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).
- Protein C Activity, Plasma. In Mayo Interpretive Handbook. Rochester: Mayo Medical Laboratories (2009).
- Revision: Joel L. Moake, MD. (2009, June). Thrombotic Disorders. Retrieved October 11, 2010, from Merck Manuals Online Library: www.merck.com